In Vivo analyzed recent public and private device financings to determine the comparative strengths and weaknesses of the various types of device financings, and further broke down the investments by therapeutic categories to examine what areas are hot and which ones are not. We found that the device industry has rebounded from a dismal public market and is showing strength among both public and private investors, resulting in a sector well-positioned for continued growth.
Deanna Deinzer and Maureen Riordan, Windhover deals analysts, assisted with the preparation of the charts and data for this article.
The last several years have marked an exciting revival of investor interest in the medical device sector. This renaissance has...